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Endovascular treatment of traumatic thoracic
aortic injury—should this be the new standard
of treatment?
Peter H. Lin, MD, Ruth L. Bush, MD, Wei Zhou, MD, Eric K. Peden, MD, and Alan B. Lumsden, MD,
Houston, TexasINTRODUCTION
Blunt trauma to the thoracic aorta is a potentially
life-threatening condition that can lead to death in 75% of
cases at the time of injury, as a result of either aortic
transection or acute rupture.1 Although it accounts for
1% of adult admissions to level I trauma centers, blunt
aortic injury represents the second most common cause of
death due to blunt trauma, second to head injury.2 It is
estimated that only 25% of patients who sustain aortic
injuries due to blunt thoracic trauma remain alive upon
arrival to the hospital. The prognosis for patients who
survive the initial injury remains poor: nearly 30% will die
within the first 6 hours, and 50% of these patients will not
live beyond the first 24 hours after the injury.3
This high mortality rate has previously prompted tradi-
tional management of blunt aortic injury to establish early
diagnosis and rapid surgical intervention to prevent a cata-
strophic rupture. This belief has been modified to allow
delay of the operative intervention to first manage other
serious concomitant injuries and lessen the high surgical
mortality rate associated with emergent aortic repair.4 De-
spite advances in modern trauma care, emergent operative
intervention for blunt aortic injury is associated with signif-
icant cardiac, pulmonary, neurologic, and hemodynamic
complications.4,5
The classic injury mechanism of blunt thoracic aorta is
related to the combination of sudden deceleration and
traction at the relatively immobile aortic isthmus, which
represents the junction between the relatively mobile aortic
arch and the fixed descending aorta. The isthmus is the
most common location for rupture (50% to 70%), followed
by the ascending aorta or aortic arch (18%) and the distal
thoracic aorta (14%).3 Patients with blunt trauma to the
thoracic aorta typically have multiple associated injuries to
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22Aother organs that can not only compound therapeutic
challenges in their surgical management but also increase
their overall morbidity and mortality.
The objectives of this chapter are to review current
treatment strategies of blunt aortic injury, including both
conventional open repair and endovascular treatment ap-
proach. Further discussions are provided on technical ma-
neuvers to facilitate endovascular treatment, potential lim-
itations of endovascular therapy, and clinical results of this
treatment modality in blunt aortic injury.
CONVENTIONAL OPEN REPAIR
The traditional therapy for blunt thoracic aortic injury
is open surgical repair. Key components of this surgical
approach typically involve a left thoracotomy, single-lung
ventilation, systemic anticoagulation, aortic cross-clamping
with interposition bypass grafting, and potential left heart
bypass with partial or total cardiopulmonary reperfusion, all
of which can lead to significant physiologic stress that
results in perioperative complications. The operative mor-
tality rate from emergency surgical repair of blunt aortic
injury is 15% to 30% in contemporary series.3,5-7 In addi-
tion to the high perioperative mortality rates associated
with an open repair, patients who sustain blunt aortic
trauma frequently have associated pulmonary contusions as
well as potential abdominal or cranial injuries that may
preclude safe or timely open surgical repair.
There have been several advances over the past decade
with respect to the conventional open repair of blunt aortic
injury. These adaptations of open surgical interventions
have decreased operative morbidity and improved treat-
ment outcome. Physicians who advocate both passive and
active methods of cardiopulmonary bypass during aortic
cross-clamping have reported decreased spinal cord isch-
emia and reduced mortality rates.3,8
Frequently, a patient with blunt aortic injury may be
unstable because of severe concomitant injuries such as
myocardial or pulmonary contusions that make it difficult
to perform open repair. Researchers have adapted delayed
operative intervention with stabilization of other concom-
itant injuries and medical optimization in an effort to
improve outcome and decrease operative complications in
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ical care medicine and refinement in surgical techniques, a
recent meta-analysis showed no definite improvement in
operative mortality over the past decade after open repair in
patients with blunt aortic injury.5
Perioperative complications after open repair for blunt
aortic injury can include bleeding, myocardial infarction,
stroke, respiratory failure, renal failure, and bowel infarc-
tion.3,6 Perhaps the most catastrophic adverse event follow-
ing an open repair is paraplegia. A recent meta-analysis
reported by von Oppell et al5 assessed the outcome of 1492
patients from 87 studies who underwent operative repair
for acute aortic trauma. The authors compared paraplegia
and hospital mortality rate with the surgical technique used
in aortic repair. The clamp-and-sew technique resulted in a
paraplegia rate of 19% and a mortality rate of 16%, whereas
distal perfusion techniques resulted in rates of 6.1% and
15%, respectively.5
In another study, Kadali et al11 reported a 20-year
experience of immediate operative repair for thoracic aortic
trauma and noted an incidence of paraplegia of 28.5% when
the clamp-and-sew technique was used, whereas patients
treated with distal perfusion had a lower incidence of
paraplegia of 3.8%. Despite the possible benefit of distal
perfusion in reducing paraplegia rate, certain complications
are associated with this technique partly because of the
need for full systemic anticoagulation, which may adversely
affect concomitant injuries involving the brain, liver, or
lungs and result in fatal hemorrhagic outcome.
Once patients overcome the possibility of these periop-
erative complications following open surgical repair, they
invariably may face a prolonged convalescent period before
regaining their baseline physical capacity. The increased
length of hospital stay after an open repair may incur
increased costs for hospitalization. The surgical treatment
strategy must always take into account the complexity of
the open chest procedure and the suboptimal outcome
often attained in patients with multiple trauma or increased
age. These concerns related to conventional open surgical
repair have prompted both physicians and endovascular
device industries to consider alternative treatment strate-
gies using a less invasive catheter-based modality.
ENDOVASCULAR REPAIR
Endovascular repair of a traumatic aortic injury is obvi-
ously a less invasive and attractive treatment alternative
compared with a conventional open repair. Early reports by
Semba et al12 and Kato et al,13 who used homemade aortic
endograft devices in the treatment of acute traumatic aortic
rupture, highlighted that this treatment strategy can be
performed successfully with a low mortality rate and no
neurologic sequelae. Over the past several years, many
researchers have similarly attested to the benefits of this
treatment strategy and reported their experience in the
treatment of blunt aortic trauma using aortic endografts
with high technical success and low mortality rates.14-19
Endovascular treatment of blunt thoracic aortic disrup-
tions offers many practical benefits and technical advan-tages compared with conventional open repair in patients
with thoracic aortic injuries. The deployment of a stent-
graft in the descending aorta with a focal traumatic lesion,
particularly in patients with adequate proximal and distal
aortic neck, can be performed in a straightforward manner.
In patients with adequate femoral artery access, this proce-
dure can even be performed under local anesthesia without
incurring significant cardiopulmonary stress. Commonly
encountered physiologic insults associated with an open
repair such as thoracotomy, aortic cross-clamping, extra-
corporeal bypass, and single-lung ventilation can all be
avoided in the setting of an endovascular thoracic aortic
endografting procedure. Exclusion of a descending aortic
disruption with an endograft does not necessitate cross-
clamping the thoracic aorta. As a result, the avoidance of
aortic cross-clamping minimizes significant blood pressure
shifts and coagulopathy. This also reduces operative blood
loss as well as ischemic events involving the spinal cord,
viscera, and kidneys. Moreover, avoidance of a thoracot-
omy has obvious convalescent advantages in patients who
might be disabled from other multiple organ injuries.
Because the traumatic force responsible for blunt aortic
disruptions frequently results in concomitant injuries in-
volving other bodily organs, prompt endovascular exclu-
sion of a traumatic aortic pseudoaneurysm or aortic tran-
section can be performed without undue delay in surgical
interventions of other concomitant injuries. This advantage
is in sharp contrast to an open aortic repair, which would
require a patient to initially recover from any major opera-
tive intervention or intensive therapy for life-threatening
complication of blunt trauma. In addition, the use of
systemic anticoagulation with heparin during an endovas-
cular aortic procedure can be reduced to a minimum, which
is particularly beneficial in patients with concomitant intra-
cranial or abdominal injuries.
Endovascular repair has many obvious advantages com-
pared with conventional open repair, but one might keep in
mind potential shortcomings of this treatment strategy.
The possibility of persistent endoleak after endovascular
exclusion of traumatic aortic pseudoaneurysm has been
reported.16,19,20 Late complications, such as endograft mi-
gration or device infection caused by fistula formation, are
still a concern.21 Furthermore, given the limited commer-
cially available endovascular devices, not all patients with
traumatic aortic disruptions have adequate aortic morphol-
ogy to undergo this repair. Finally, critics of this treatment
strategy often cite the lack of long-term durability studies
to justify the use of an aortic endograft in young trauma
victims who may well tolerate the physiologic stress associ-
ated with an open repair.
Anatomic consideration in endovascular repair of
traumatic aortic injury. Several fundamental differences
in the anatomic morphology between patients with athero-
sclerotic thoracic aortic aneurysm and traumatic aortic in-
juries may impact on the choice of endograft devices and
deployment techniques. In patients with descending tho-
racic aneurysms, adequate proximal and distal aortic neck
length is critical to ensure proper device fixation and aneu-
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important for device selection. Because the diameter of an
aortic neck may be subject to continual expansion caused,
in part, by aneurysm progression, many stent-graft devices
have incorporated components such as hooks and proximal
bare metal to reinforce device fixation and minimize stent-
graft migration.
Other pertinent factors in treating patients with tho-
racic aortic aneurysms include proximity to the celiac ar-
tery, thrombus in the aneurysm sac, length of aneurysm
involving intercostal arteries, and pre-existing thrombus in
the aortic landing zones. These considerations may play
critical roles in subsequent aneurysm remodeling following
endovascular repair, which may result in aneurysm size
regression and alter stent-graft fixation. Access vessels are
also an important consideration. Since most patients with
thoracic aneurysms are elderly men with underlying athero-
sclerotic disease, the insertion of a large thoracic endovas-
cular device using a 21F introducer may require a retroper-
itoneal access with the creation of an iliac artery conduit.
Many of these considerations are different when pa-
tients with traumatic aortic disruption are treated. Because
most aortic disruptions are located in the proximal de-
scending thoracic aorta, the proximal landing zone is gen-
erally near the left subclavian artery. The distal landing
zone, on the other hand, is usually not a critical factor
because the long segment of normal descending thoracic
aorta is more than sufficient to permit proper device fixa-
tion. To ensure proper proximal device fixation in trau-
matic aortic injury, many have raised the concern that the
left subclavian artery will be intentionally covered by the
endograft in a significant number of patients. Clinical ex-
periences have shown that critical limb-threatening isch-
emia of the left arm rarely occur and, if necessary, can be
reversed by an elective left carotid-to-subclavian artery by-
pass grafting procedure (Fig 1).22-24 Because the endograft
device is anchored in relatively normal proximal and distal
aortic segment, there is very little concern regarding the
possibility of subsequent aortic neck enlargement that is
the case in the aneurysm population. The possibility of
device migration or late endoleak in the trauma population,
while possible, is less likely and worrisome compared with
the aneurysm cohorts.
The main anatomic challenge of endovascular treat-
ment of traumatic aortic injury is related to the relatively
small aortic diameter in these young victims compared with
elderly patients with thoracic aortic aneurysm. Although
the GORE TAG Thoracic Endoprosthesis (W. L. Gore &
Associates, Flagstaff, Ariz) is currently the only device that
has received the United States Food and Drug Administra-
tion (FDA) approval for clinical application, this device is
designed for patients with thoracic aortic aneurysms who
typically have larger aortic diameters.
In a recent study by Borsa et al,25 who analyzed the
angiographic morphology of 50 traumatic victims with
thoracic aortic disruptions, the mean aortic diameters adja-
cent to the aortic injury was 19.3 mm. The available GORE
TAG devices range from 26 mm to 40 mm in diameter.Because this device was not designed in the treatment of
traumatic aortic injuries, placement of even the smallest
available GORE TAG device in trauma patients will likely
represent a significant and inappropriate device oversize,
which might lead to inadequate device fixation. This sce-
nario was highlighted by a recent case report in which a
GORE TAG device was used in a 20-year-old trauma
victim.26 The severe device oversize caused the GORE
TAG device to collapse within the aortic lumen, and this
was subsequently treated by another stent-graft insertion
which unfolded the collapsed endograft.26 Appropriately
sized thoracic endografts with smaller diameters must be
made available for endovascular therapy to be a viable
treatment strategy in patients with traumatic aortic injuries.
Adjunctive maneuvers to facilitate endovascular
placement of thoracic endografts. Several adjunctive en-
dovascular techniques have been described that may facili-
tate the deployment of a thoracic stent-graft. These maneu-
vers, which have been used in the endovascular treatment of
both traumatic and aneurysmal aortic lesions, include gain-
ing brachial artery access, femoral artery guidewire place-
ment, controlled hypotension, and transient asystole in-
duced by adenosine administration.
A. Accessing the brachial artery and femoral artery
guidewire placement. Because most traumatic aortic dis-
ruptions occur distal to the left subclavian artery, accessing
the left brachial artery followed by the placement of a
diagnostic catheter allows continuous visualization of the
left subclavian artery. This greatly enhances the identifica-
tion of the proximal landing zone when a thoracic stent-
graft is deployed.24 To facilitate the delivery of an endograft
to the proximal descending thoracic aorta, a useful tech-
nique is to place a stiff guidewire from the femoral artery to
the right axillary artery via the innominate artery. This
Fig 1. A, A thoracic aortogram demonstrates a large aortic pseu-
doaneurysm caused by a blunt thoracic injury that occurred just
distal to the left subclavian artery. B, Computed tomography
angiography of the chest following successful endovascular pseu-
doaneurysm exclusion with a left carotid-to-subclavian bypass
graft.24provides an excellent tracking of the device through the
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artery.27
In a situation where a severe tortuous aortic arch is
encountered, a 260-cm stiff guidewire may be exteriorized
from both the femoral and right brachial access site. This
can be accomplished by first placing a soft floppy guidewire
in the aortic arch from the femoral artery. A snare catheter
is used from the right brachial artery to capture the floppy
wire, which is exteriorized through the right brachial artery
introducer sheath. A guidewire exchange is performed in
which a long, stiff guidewire is placed between the femoral
and right brachial artery. Tension on both ends of the stiff
wire may then be used to help the large-access sheaths
traverse regions of angulation in the iliac vessels or within
the aortic arch. The subclavian and the innominate arteries
should be protected from direct trauma caused by the
shearing of the stiff guidewire. This can be accomplished by
placing an angiographic catheter over the guidewire within
the aortic arch. Both the guidewire and angiographic cath-
eter should remain together throughout the procedure.
B. Controlled hypotension to facilitate stent-graft deploy-
ment. Many early clinical studies documented the propen-
sity of stent-graft displacement or caudal movement during
deployment, a phenomenon largely caused by the high
blood flow in the descending aorta.28-30 This scenario was
particularly problematic with stent-grafts composed of a
balloon-expandable stent attached to a graft material, par-
ticularly in many early clinical reports of the use of home-
made devices.29,31,32
Many physicians have reported the benefit of con-
trolled hypotension to lower the mean arterial blood pres-
sure to between 50 to 60 mm Hg by administration of
intravenous sodium nitroprusside. This is performed just
before the stent-graft deployment in an effort to reduce the
risk of downstream migration caused by intra-aortic blood
flow during deployment. When the stent-graft position is
appropriate and the blood pressure is optimal, the stent-
graft is deployed by rapidly withdrawing the sheath while
the pusher mandrel is held firmly in position. Immediately
after stent-graft deployment, the nitroprusside infusion is
discontinued to normalize the blood pressure.
C. Adenosine-induced cardiac asystole during stent-
graft deployment. The administration of intravenous aden-
osine to produce temporary cardiac asystole to enhance the
precision of placement of thoracic endoluminal devices was
first reported by Dorros and Cohn in 1996.33 The effec-
tiveness of this agent in transiently arresting cardiac flow
during thoracic endovascular procedure has also been re-
ported by others.34-36 The administration of intravenous
adenosine produced a predictable and reproducible period
of asystole of 15 to 30 seconds before spontaneous return
of sinus rhythm. Asystole allowed graft deployment with-
out the risk of displacement by blood flow, particularly in
the upper thoracic aorta. The bolus dose required to pro-
duce this effect ranged from 12 to 45 mg and was repro-
ducible in the same patient. No deleterious effects from
transient cardiac asystole caused by adenosine infusion dur-
ing endovascular thoracic aortic procedure have been re-ported in the literature. Most physicians agree that adeno-
sine may be administered safely in selected patients,
particularly those requiring precise deployment of the graft
high in the proximal descending thoracic aorta.
Results from clinical series in acute traumatic aortic
injuries. Available literature on endovascular treatment of
traumatic aortic injuries remains relatively scarce, in contrast
to the vast body of literature on endovascular abdominal aortic
aneurysm repair. Nonetheless, nearly all reported series under-
scored significant advantages of endovascular treatment of
blunt aortic trauma, which include excellent technical success
and low mortality rates (Table I).12,15-20,27,37-49
Thompson et al48 reported on encouraging outcome
after endovascular thoracic aortic repair for acute traumatic
rupture in five patients. The technical success rate was
100%; no procedure-related complication or death was
observed during an average follow-up of 20 months.48
Fattori et al39 described 11 patients with acute and
eight with chronic thoracic traumatic injury located at the
aortic isthmus treated by endovascular stent-grafting. All
procedures resulted in a successful outcome without signs
of endoleaks. No death, paraplegia, or other complications
were observed. The study group detected one type III
endoleak during a mean follow-up period of 20 months,
which showed spontaneous thrombosis within 2 months.39
Lachat et al42 reported complete technical success in 12
patients with acute traumatic aortic rupture who were
treated by self-expanding stent-grafts.42 The in-hospital
mortality was 8% due to an undetected residual type I
endoleak. During the mean follow-up time of 17 months,
one patient experienced a perigraft leakage that was treated
by an additional stent-graft 12 months postoperatively.42
Wellons et al27 reported nine patients with traumatic
aortic injuries who all underwent endovascular repair using
infrarenal aortic cuff extenders. There were no procedure-
related deaths and technical success was achieved in all
patients.
Two recent studies compared the treatment outcome
of traumatic thoracic aortic disruption between conven-
tional open repair vs endovascular therapy. Ott et al16
reported their experience of 18 patients with blunt thoracic
aortic injuries during an 11-year period. The authors noted
that the open surgical group had a 17% early mortality rate,
a paraplegia rate of 16%, and an 8.3% incidence of recurrent
laryngeal nerve injury. This is in sharp contrast to the
endovascular patient cohorts, who did not experience any
perioperative mortality, paraplegia, or recurrent laryngeal
nerve injury.16 Similar findings regarding the benefits of
endovascular treatment over open surgical repair were
highlighted in another study by Kasirajan et al.18 These
authors noted that patients who underwent endovascular
repair had significantly lower perioperative mortality rates
compared with those who underwent open repair. The
mean procedural time and length of hospital stay were all
significantly less in the endovascular group than in the open
repair cohort.18
Paraplegia, undoubtedly the most feared complication
following repair of a traumatic aortic injury, has a reported
ent, G
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blunt aortic trauma.6 A postulated mechanism of this com-
plication relates to aortic cross-clamp times 30 minutes.
An overview of all available endovascular studies on trau-
matic aortic injuries showed that the paraplegic complica-
tion does not occur. Table I summarizes the treatment
outcome of these studies. One possible explanation of this
low paraplegic incidence following endovascular treatment
is the avoidance of aortic cross-clamping and less blood
pressure variation or hemodynamic instability after endo-
vascular repair.
Challenges of endovascular repair of traumatic aortic
injury in young patients. Endovascular treatment of trau-
matic aortic injuries comes with certain challenges. Trau-
matic aortic injuries tend to affect younger populations, in
contrast to the aneurysm population. It is not uncommon
that adolescent or pediatric patients may present with this
injury. Because of potential vessel expansion as a result of
normal aortic growth, placement of a stent-graft in young
patients must be viewed with extreme caution. The possi-
bility of stent-graft migration may occur as the aorta en-
larges because of expected growth in young patients.
Endovascular repair in selected pediatric patients may
be considered as a temporary bridge to a more definitive
operative repair at a later stage. In pediatric patients with
life-threatening aortic disruption who have other concom-
itant injuries, it may be appropriate to perform endovascu-
lar repair to exclude the aortic injury until the patients fully
recover from other injuries and can undergo an elective
definitive open repair with proven long-term durability.
An important anatomic consideration in endovascular
treatment of traumatic aortic injuries in young patients
relates to their tapering luminal diameter of the descending
thoracic aorta. Moreover, younger patients typically have
higher aortic pulsatile compliance and flow velocity than do
elderly patients, which represents a hemodynamic factor
Table I. Clinical series of endovascular treatment of acute
Author Year
Patients
(N)
Technical
success (%)
Bortone46 2002 10 100 Gor
Orend45 2002 11 92 Gor
Thompson47 2002 5 100 Gor
Fattori39 2002 11 100 Gor
Lachat42 2002 12 100 Gor
Kasirajan18 2003 5 100 Gor
Karmy-Jones19 2003 11 100 Ane
Iannelli15 2004 3 100 Gor
Wellons27 2004 9 100 Ane
Kato41 2004 6 100 Ho
Scheinert17 2004 10 100 Gor
Czermak38 2004 12 92 Gor
Morishita43 2004 7 100 Ho
Neuhauser44 2004 10 100 Gor
Ott16 2004 6 100 Tal
Uzieblo20 2004 4 100 Tal
Bortone37 2004 14 100 Talthat may destabilize aortic endograft fixation.49,50 Implan-tation of currently available nontapered thoracic endografts
in young trauma victims who have relatively narrow aortic
lumens will likely lead to diameter mismatch and endograft
oversize. Gross oversizing in a relatively small diameter
aorta in combination with a short radius of aortic arch
curvature can result in a suboptimal conformability along
the inner curve of the aortic arch, which can lead to
problems including device fracture, endoleak, migration,
and infolding (Fig 2).
It is estimated that these types of device-related com-
plications, such as stent fracture, stent-graft compression,
rate of reintervention, device explanation, or endoleak,
occurred in approximately 3% when used in traumatic
aortic disruptions.14,15,23,37,39,47,51-54 Moreover, a semi-
rigid stent graft in a tightly curved arch may tend to lift the
inferior wall of the lesser curve (Fig 2). Force of cardiac
Fig 2. In the clinical situation of an oversized endograft placed in
a small aorta with a tight aortic curvature, the device fails to appose
the inner curvature. Infolding of the lower lip of the graft can occur
with catastrophic consequences. This has not occurred when the
device is sized according to the directions for use.
matic aortic injuries
Endograft type Paraplegia
Follow-up
(months)
None 14
lent None 14
stom None 20
lent None 20
lent None 9
lent, homemade None 10
cuff, Ancure, Talent, homemade None 16
None 13
cuff, Excluder cuff None 6
de None 6
lent None 17
lent None 9
de None 12
lent, Vanguard None 26
None 16
None 8
ore, Zenith, Endofit None 14trau
e
e, Ta
e, cu
e, Ta
e, Ta
e, Ta
uRx
e
uRx
mema
e, Ta
e, Ta
mema
e, Ta
ent
entpulsations pushing the stent graft against the outer curva-
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inner curvature. Some stent grafts may also adopt a fish-
mouth configuration with the superior-inferior diameter of
the proximal graft shortening and the lateral diameter
widening, thus decreasing graft-wall apposition superiorly
and inferiorly.
Because the GORE TAG device remains the only FDA-
approved thoracic endograft at the present time, available
reports demonstrated that approximately 9% of its reported
applications occur in trauma patients.14,15,23,37,39,47,51-54
This is the scenario when significant device oversize is most
likely to occur due in part to the lack of small diameter
endografts to be placed in young trauma patients with
relatively narrow thoracic aortic lumen. All adverse events
reported to date with the use of GORE TAG device were
largely due to device oversize beyond the recommended
FDA-approved Instructions for Use (Table II).
Anther important challenge in endovascular repair of
traumatic aortic injuries is the limited availability of stent-
graft devices. Several authors have reported successful us-
age of infrarenal aortic endograft cuffs in excluding thoracic
aortic injuries, but this remains a less than ideal endovascu-
lar solution.19,27 Current FDA-approved endovascular de-
vices for infrarenal aortic aneurysm such as AneuRx
(Medtronic, Santa Rosa, Calif), Zenith (Cook, Indianapo-
lis, Ind), Endologix (Irvine, Calif), and Gore Excluder
endograft all have aortic extension cuffs that are designed
for delivery to the infrarenal aorta. The lengths of these
delivery devices range from 55 cm to 65 cm, which may not
be sufficient for juxta-subclavian artery deployment; this
may be a particular concern in tall patients (Table III). A
retroperitoneal iliac artery conduit may provide an added
advantage of delivering an endograft device to a more
proximal location, but these cuffs are generally short in
length, and multiple aortic cuff placement will likely be
required to adequately exclude an aortic disruption. With-
out clear evidence to demonstrate the efficacy of placing
multiple aortic cuffs as an effective treatment in traumatic
aortic disruptions, this treatment strategy represents an
off-labeled device application and should not be widely
encouraged.
Delivering and deploying thoracic endovascular devices
may pose certain technical challenges in young trauma
victims with aortic injuries. Because younger patients with
relatively normal aorta frequently have a sharp aortic angu-
lation just distal to the left subclavian artery, it may be
difficult to accurately position and deploy a thoracic stent-
graft in a juxta-subclavian artery location, particularly if the
endograft has a rigid or relatively non-flexible device shaft.
In some thoracic endovascular devices, such as the Talent
endografts (Medtronic) the proximal bare stents need to be
deployed higher in the aortic arch. The stent-graft portion
of the device is then slowly pulled back in the descending
thoracic aorta to allow accurate deployment.
Manipulation of an endograft in the vicinity of the
ascending aorta not only is technically difficult but also
carries a higher risk of stroke complications. Numerous
complications related to manipulation of bulky devices inthe aortic arch have been reported, including cardiac per-
foration, aortic valve injury, arch perforation, branch vessel
rupture, and cerebral embolization.12,13,15,29-32,54-57 Sig-
nificant device refinement, such as a more flexible shaft to
accommodate aortic curvature, will undoubted be neces-
sary before this technology can be widely adapted in young
patients with traumatic aortic injuries.
Femoral arterial access represents a potential challenge
Table II. Considerations and requirements for successful
endografting in the trauma patient
Anatomic consideration of blunt aortic injury in young trauma
patients
● Smaller radius of curvature (compared to older patients with
aortic aneurysm)
● Smaller aortic diameter (compared to older patients with
aortic aneurysm)
● Small iliac or femoral access vessel diameter
● Aortic disruption typically located immediately distal to the
left subclavian artery
GORE TAG Thoracic Endoprosthesis Instructions for Use as
approved by the FDA:
● Healthy neck length minimum 2 cm—may cover left
subclavian artery if necessary
● The GORE TAG device has been designed to be oversized
from 7% to 18%, which has been incorporated into the
sizing guide (do not oversize and follow sizing chart)
● Measure flow lumen, do not include adventitia or calcium
but include thrombus if present
● Use case planning forms
● Neck taper must be within device sizing range—especially
important around the arch transition
● Neck angles 60° recommend more than 2 cm of neck
engagement
Device should contact entire circumference of aorta especially the
proximal end inner curve
Caution: Given the smallest GORE TAG device has a diameter
of 26 mm, placement of such a device can result in varying
degree of oversize in various aortic diameter. The following
description summarizes varying degree of device oversize in
various scenarios of aortic diameters:
● Placement of a 26-mm thoracic endograft in a 20-mm aortic
diameter would result in a 30% oversize.
● Placement of a 26-mm thoracic endograft in a 18-mm aortic
diameter would result in a 44% oversize.
● Placement of a 26-mm thoracic endograft in a 16-mm aortic
diameter would result in a 63% oversize.
● Placement of a 26-mm thoracic endograft in a 14-mm aortic
diameter would result in a 86% oversize.
Table III. Delivery system lengths and diameters
of aortic extender cuffs currently approved for infrarenal
aneurysm repair
Device
Delivery
system
shaft length
Maximum
stent-graft
diameter
Stent-graft
length
Medtronic AneuRx 55 cm 28 mm 3.75 cm
GORE Excluder 61 cm 28.5 mm 3.3 cm
Cook Zenith 55 cm 32 mm 3.6 cm
Endologix PowerLink 63 cm 28 mm 5.5-7.5 cmwhen considering endovascular thoracic aortic repair, par-
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racic endograft devices require a minimum 20F introducer
sheath. Placement of such a large introducer sheath in a
diseased artery or small ileofemoral vessels 8 mm in
diameter can result in severe iatrogenic injuries, including
arterial dissection and rupture.58 If significant resistance is
encountered during the insertion of an introducer sheath,
one should stop the insertion process and carefully with-
draw the introducer sheath. A retroperitoneal access with
the creation of an iliac or aortic conduit should be consid-
ered to limit the risk of iatrogenic rupture associated with
small femoral artery access. These conduits can be con-
verted to an ileofemoral or aortofemoral bypass graft to
improve the inflow of an ischemic extremity if necessary.
The potential of iatrogenic femoral artery injury in
endovascular thoracic repair is highlighted in a study by
White et al,58 who noted a 27% rate of access complica-
tions. However, as endovascular devices undergo continual
refinement and miniaturization with smaller introducer
sheaths, the incidence of iatrogenic access complications
will likely be decreased or possibly avoided.
Should endovascular repair be considered the new
standard of treatment in traumatic aortic injury?
Because of the rarity of traumatic aortic injury, successful
endovascular treatment will likely be confined to large
trauma centers with a dedicated trauma team working
jointly with experienced endovascular surgeons. Moreover,
optimal outcome of this treatment strategy will depend on
proper imaging equipment and full arrays of readily avail-
able endovascular devices. We believe that an emergent
stent-grafting is more technically demanding and concep-
tually challenging than an elective endovascular procedure.
In an elective aneurysm stent-grafting procedure, for in-
stance, careful consideration regarding device sizing and
device selection can be done in a timely fashion. In contrast,
urgent endovascular repair of a traumatic aortic injury
requires an experienced team of trauma surgeons, vascular
surgeons, anesthesiologists, and operating room nurses
ready to perform this procedure in critically injured trauma
patients in an around-the-clock fashion. Physicians must
rely on their expertise and skills to make critical decisions
relating to device selection or arterial access both promptly
and accurately. Although all available clinical studies on
endovascular treatment of traumatic aortic disruptions
showed promising results with excellent technical success
and lower mortality rates compared with conventional
open repair, long term studies will undoubtedly be neces-
sary to prove the treatment efficacy of this minimally-
invasive therapy.
Presently, the Achilles heel of endovascular treatment
of traumatic aortic disruption relates to the limited avail-
ability of thoracic endografts in all sizes (Table II). Utiliz-
ing currently approved thoracic devices in young trauma
victims with aortic injuries will likely result in significant
device oversize and potentially lead to late device-related
complications (Table II). Until further studies that validate
this treatment durability are reported and the full array of
appropriately sized devices becomes available, physiciansmust take precautions when performing endovascular re-
pair of traumatic aortic injuries, as this therapy should only
be offered in appropriately selected patients.
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